Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: France Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20034
20051
20062
20073
20084
20101
20121
20134
20142
20161
20172
20181
20195
20201
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated7
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi9
Bayer3
Boehringer Ingelheim3
Daiichi Sankyo3
Assistance Publique - Hôpitaux de Paris2
Bristol-Myers Squibb2
Janssen Scientific Affairs, LLC2
Advanz Pharma1
Assistance Publique Hopitaux De Marseille1
Atrial Fibrillation Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation39
Stroke7
Arrhythmias, Cardiac5
Atrial Flutter3
Cardiovascular Diseases2
Cerebral Hemorrhage2
Coronary Artery Disease2
Embolism2
Heart Diseases2
Ischemic Stroke2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.